COVID-19 Impact on Moderna Inc
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The coronavirus (COVID-19) company impact report analyses how the pandemic will impact Moderna Inc. performance.
Moderna is a pipeline biotech company
Moderna’s focus is on mRNA-based prophylactic and therapeutic vaccines
Moderna’s pipeline is most active in early stages of drug development
mRNA-1273 is Moderna’s main weapon against COVID-19
Scope
This 30-page PowerPoint based report gives an important expert analysis on how COVID-19 will affect Moderna Incorporated. Findings are based on the industry’s most comprehensive platform the Pharma Intelligence Center, including Deals, News, Drugs, Sales, Clinical Trials database and recent analysis.
Reasons to Buy
An overview of how Moderna Inc. will be affected by the COVID-19 pandemic.
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.